StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3043% below fair value
$80.79−4.78 (-5.59%)

Close on Nov 19, 2026Market cap $33.38BP/E 13.3Yield 2.51%

Zoetis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Zoetis's pe ratio was 13.5× on Nov 11, 2026, against 21.8× a year earlier. Over the last 5 years it ranged from 11.4× to 58.8×, with a median of 33.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.5×−7.9
2025Dec 31, 202521.4×−9.3
2024Dec 31, 202430.6×−9.5
2023Dec 29, 202340.1×+6.7
2022Dec 30, 202233.5×−25.3
2021Dec 31, 202158.8×+11.1
2020Dec 31, 202047.7×+4.0
2019Dec 31, 201943.7×+7.7
2018Dec 31, 201835.9×−2.0
2017Dec 29, 201737.9×−0.9
2016Dec 30, 201638.8×−15.1
2015Dec 31, 201553.8×+15.4
2014Dec 31, 201438.4×−3.5
2013Dec 31, 201341.9×–

More Zoetis figures

See a number that looks wrong?